Fermenta Biotech Limited lists its equity shares on the National Stock Exchange of India (NSE) on August 4, 2026, marking a new stage in its 75-year operating history. The company continues to trade on the Bombay Stock Exchange (BSE), maintaining a dual-exchange presence. According to the company, a total of 294,30,987 equity shares of face value ₹5 each are admitted for trading on the NSE under the symbol “FERMENTA” with ISIN INE225B01021. Shares are also expected to remain available under the BSE scrip code 506414.
The company is described as one of the world’s largest manufacturers of Vitamin D3 active pharmaceutical ingredients (API). It also supplies nutritional ingredients, green chemistry solutions, specialised APIs, and customised food premixes.
The NSE debut is presented as a step toward improving investor access, market visibility, and price discovery. The listing is accompanied by a ceremonial bell-ringing event at NSE’s Exchange Plaza in Mumbai. Company representatives and NSE officials attend, and management notes the move supports broader participation while reinforcing commitments to transparency and shareholder engagement.